We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
(+2.6%)
Cap. Flow
-$89M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$48.8M |
| 2 |
Procter & Gamble
PG
|
+$24.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$23.6M |
| 4 |
Keysight
KEYS
|
+$23.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$46.5M |
| 2 |
ExxonMobil
XOM
|
+$36.6M |
| 3 |
GG
Goldcorp Inc
GG
|
+$24.9M |
| 4 |
Walt Disney
DIS
|
+$23.8M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.16% |
| 2 | Technology | 16.87% |
| 3 | Financials | 10.38% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
XEC
376
DELISTED
CIMAREX ENERGY CO
XEC
| $3.85M | 0.05% |
65,135
-62,412
| -49% | -$3.99M |
|
377
SBA Communications
SBAC
$18.4B
| $3.84M | 0.05% |
17,165
+233
| +1% | +$49.2K |
|
378
Revvity
RVTY
$12.3B
| $3.84M | 0.05% |
40,000
| – | – |
|
379
Planet Fitness
PLNT
$4.23B
| $3.84M | 0.05% |
53,191
+8,491
| +19% | +$640K |
|
|
WCG
380
DELISTED
Wellcare Health Plans, Inc.
WCG
| $3.81M | 0.05% |
13,439
+9,379
| +231% | +$2.59M |
|
381
Vanda Pharmaceuticals
VNDA
$312M
| $3.8M | 0.05% |
271,000
| – | – |
|
382
Intercontinental Exchange
ICE
$82.4B
| $3.78M | 0.05% |
44,140
-992
| -2% | -$81K |
|
383
ServiceNow
NOW
$102B
| $3.77M | 0.05% |
69,040
-200
| -0.3% | -$10.5K |
|
384
Telus
TU
$16B
| $3.77M | 0.05% |
204,268
-111,522
| -35% | -$2.06M |
|
385
Edison International
EIX
$30.7B
| $3.75M | 0.05% |
55,871
-85,865
| -61% | -$5.33M |
|
386
Hewlett Packard
HPE
$63.2B
| $3.67M | 0.05% |
246,301
+222
| +0.1% | +$3.36K |
|
387
BHP
BHP
$213B
| $3.66M | 0.05% |
71
+9
| +15% | +$435 |
|
388
Martin Marietta Materials
MLM
$33.6B
| $3.6M | 0.04% |
15,694
-8,068
| -34% | -$1.75M |
|
389
Banco Santander
SAN
$194B
| $3.59M | 0.04% |
818
+69
| +9% | +$310 |
|
390
Corpay
CPAY
$24.2B
| $3.58M | 0.04% |
12,808
+7,406
| +137% | +$1.94M |
|
391
D.R. Horton
DHI
$41B
| $3.56M | 0.04% |
82,949
-179,430
| -68% | -$7.94M |
|
392
Equity Residential
EQR
$25.4B
| $3.56M | 0.04% |
47,066
+911
| +2% | +$69.6K |
|
|
SCHW
393
Charles Schwab
SCHW
$177B
| $3.51M | 0.04% |
87,682
+1,230
| +1% | +$53.6K |
|
394
Canadian Imperial Bank of Commerce
CM
$107B
| $3.48M | 0.04% |
88,584
-47,316
| -35% | -$1.91M |
|
395
Truist Financial
TFC
$63.2B
| $3.46M | 0.04% |
70,632
-1,234
| -2% | -$60.4K |
|
396
AutoZone
AZO
$48.3B
| $3.44M | 0.04% |
3,147
+932
| +42% | +$981K |
|
397
Brookfield
BN
$102B
| $3.44M | 0.04% |
202,240
-71,472
| -26% | -$1.21M |
|
398
TotalEnergies
TTE
$193B
| $3.4M | 0.04% |
61
+6
| +11% | +$328 |
|
|
ISCA
399
DELISTED
International Speedway Corp
ISCA
| $3.38M | 0.04% |
+75,631
| New | +$3.34M |
|
400
Yum China
YUMC
$14.9B
| $3.37M | 0.04% |
+73,170
| New | +$3.18M |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2019 Portfolio in Review
As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
- Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
- Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
- Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
- Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
- Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
- Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.
Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.